These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35954257)

  • 21. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer's disease in the 3xTg-AD mouse model.
    Grimaldi A; Brighi C; Peruzzi G; Ragozzino D; Bonanni V; Limatola C; Ruocco G; Di Angelantonio S
    Cell Death Dis; 2018 Jun; 9(6):685. PubMed ID: 29880901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI.
    Uras I; Karayel-Basar M; Sahin B; Baykal AT
    Alzheimers Dement; 2023 Oct; 19(10):4572-4589. PubMed ID: 36934297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.
    Korkmaz OT; Ay H; Aytan N; Carreras I; Kowall NW; Dedeoglu A; Tuncel N
    J Mol Neurosci; 2019 Jul; 68(3):389-396. PubMed ID: 30498985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer's Disease Are Linked with Neurotransmitter Alterations.
    Araya-Arriagada J; Bello F; Shivashankar G; Neira D; Durán-Aniotz C; Acosta ML; Escobar MJ; Hetz C; Chacón M; Palacios AG
    J Alzheimers Dis; 2021; 82(s1):S5-S18. PubMed ID: 33749647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
    Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
    J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.
    Gnoth K; Piechotta A; Kleinschmidt M; Konrath S; Schenk M; Taudte N; Ramsbeck D; Rieckmann V; Geissler S; Eichentopf R; Barendrecht S; Hartlage-Rübsamen M; Demuth HU; Roßner S; Cynis H; Rahfeld JU; Schilling S
    Alzheimers Res Ther; 2020 Nov; 12(1):149. PubMed ID: 33189132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease.
    Zhang M; Zhang Z; Li H; Xia Y; Xing M; Xiao C; Cai W; Bu L; Li Y; Park TE; Tang Y; Ye X; Lin WJ
    Transl Neurodegener; 2024 Jan; 13(1):1. PubMed ID: 38173017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice.
    Park SW; Kim JH; Mook-Jung I; Kim KW; Park WJ; Park KH; Kim JH
    Neurobiol Aging; 2014 Sep; 35(9):2013-20. PubMed ID: 24709310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease.
    Devi L; Alldred MJ; Ginsberg SD; Ohno M
    PLoS One; 2012; 7(3):e32792. PubMed ID: 22403710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive optical imaging of retinal Aβ plaques using curcumin loaded polymeric micelles in APP
    Chibhabha F; Yang Y; Ying K; Jia F; Zhang Q; Ullah S; Liang Z; Xie M; Li F
    J Mater Chem B; 2020 Aug; 8(33):7438-7452. PubMed ID: 32662804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
    Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
    PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of alzheimer's disease.
    Govindarajan K; Kar S
    J Nanobiotechnology; 2023 Jul; 21(1):216. PubMed ID: 37424018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer's Disease.
    Lim JKH; Li QX; He Z; Vingrys AJ; Chinnery HR; Mullen J; Bui BV; Nguyen CTO
    Front Neurosci; 2020; 14():862. PubMed ID: 32903645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of Exogenous Butyrylcholinesterase with β-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain.
    Reid GA; Darvesh S
    Curr Alzheimer Res; 2021; 18(6):470-481. PubMed ID: 34455970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease-associated β-amyloid does not protect against herpes simplex virus 1 infection in the mouse brain.
    Bocharova O; Pandit NP; Molesworth K; Fisher A; Mychko O; Makarava N; Baskakov IV
    J Biol Chem; 2021 Jul; 297(1):100845. PubMed ID: 34052228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
    Devi L; Ohno M
    Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.